Cancer Genetics, Inc. Announces Distribution Partnership With Nikon Instruments Inc.
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
RUTHERFORD, N.J.--(BUSINESS WIRE)--Cancer Genetics, Inc.’s (OTCQB: CGIX) (“CGI” or the “Company”) wholly-owned subsidiary, Cancer Genetics Italia, S.r.l. (“CGI Italia”), has entered into an agreement with Nikon Instruments S.p.A. (“Nikon”) for the distribution of oncology-focused DNA Probes intended for fluorescence in situ hybridization (“FISH”) in the Italian market. This new partnership extends CGI’s global distribution network and provides more evidence that its best-in-class cancer diagnostic technologies are becoming widely accepted in the global oncology healthcare community.
Help employers find you! Check out all the jobs and post your resume.
RUTHERFORD, N.J.--(BUSINESS WIRE)--Cancer Genetics, Inc.’s (OTCQB: CGIX) (“CGI” or the “Company”) wholly-owned subsidiary, Cancer Genetics Italia, S.r.l. (“CGI Italia”), has entered into an agreement with Nikon Instruments S.p.A. (“Nikon”) for the distribution of oncology-focused DNA Probes intended for fluorescence in situ hybridization (“FISH”) in the Italian market. This new partnership extends CGI’s global distribution network and provides more evidence that its best-in-class cancer diagnostic technologies are becoming widely accepted in the global oncology healthcare community.
Help employers find you! Check out all the jobs and post your resume.